Intravascular stents

Gregory D. Chapman, Roger S. Gammon, Robert P. Bauman, Richard S. Stack

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Intravascular stents have been developed to address acute arterial closure and restenosis, the major limitations of percutaneous transluminal coronary angioplasty (PTCA). Metallic stents in human clinical trials have shown efficacy in treating acute closure and, in selected patients, lowering the restenosis rate. This review delineates the characteristics of the ideal stent and examines ongoing clinical trials that are evaluating various stent prototypes. Developmental stents that use radiopaque and bioabsorbable materials are presented. The potential role for intravascular stents as vehicles for localized drug delivery and gene therapy is discussed.

Original languageEnglish
Pages (from-to)127-131
Number of pages5
JournalTrends in Cardiovascular Medicine
Volume1
Issue number3
DOIs
StatePublished - Jan 1 1991
Externally publishedYes

Fingerprint

Stents
Clinical Trials
Coronary Balloon Angioplasty
Genetic Therapy
Drug Therapy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Chapman, G. D., Gammon, R. S., Bauman, R. P., & Stack, R. S. (1991). Intravascular stents. Trends in Cardiovascular Medicine, 1(3), 127-131. https://doi.org/10.1016/1050-1738(91)90007-2

Intravascular stents. / Chapman, Gregory D.; Gammon, Roger S.; Bauman, Robert P.; Stack, Richard S.

In: Trends in Cardiovascular Medicine, Vol. 1, No. 3, 01.01.1991, p. 127-131.

Research output: Contribution to journalArticle

Chapman, GD, Gammon, RS, Bauman, RP & Stack, RS 1991, 'Intravascular stents', Trends in Cardiovascular Medicine, vol. 1, no. 3, pp. 127-131. https://doi.org/10.1016/1050-1738(91)90007-2
Chapman GD, Gammon RS, Bauman RP, Stack RS. Intravascular stents. Trends in Cardiovascular Medicine. 1991 Jan 1;1(3):127-131. https://doi.org/10.1016/1050-1738(91)90007-2
Chapman, Gregory D. ; Gammon, Roger S. ; Bauman, Robert P. ; Stack, Richard S. / Intravascular stents. In: Trends in Cardiovascular Medicine. 1991 ; Vol. 1, No. 3. pp. 127-131.
@article{46ea12d1f3bc4a2aa570f10a2ef946a3,
title = "Intravascular stents",
abstract = "Intravascular stents have been developed to address acute arterial closure and restenosis, the major limitations of percutaneous transluminal coronary angioplasty (PTCA). Metallic stents in human clinical trials have shown efficacy in treating acute closure and, in selected patients, lowering the restenosis rate. This review delineates the characteristics of the ideal stent and examines ongoing clinical trials that are evaluating various stent prototypes. Developmental stents that use radiopaque and bioabsorbable materials are presented. The potential role for intravascular stents as vehicles for localized drug delivery and gene therapy is discussed.",
author = "Chapman, {Gregory D.} and Gammon, {Roger S.} and Bauman, {Robert P.} and Stack, {Richard S.}",
year = "1991",
month = "1",
day = "1",
doi = "10.1016/1050-1738(91)90007-2",
language = "English",
volume = "1",
pages = "127--131",
journal = "Trends in Cardiovascular Medicine",
issn = "1050-1738",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Intravascular stents

AU - Chapman, Gregory D.

AU - Gammon, Roger S.

AU - Bauman, Robert P.

AU - Stack, Richard S.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - Intravascular stents have been developed to address acute arterial closure and restenosis, the major limitations of percutaneous transluminal coronary angioplasty (PTCA). Metallic stents in human clinical trials have shown efficacy in treating acute closure and, in selected patients, lowering the restenosis rate. This review delineates the characteristics of the ideal stent and examines ongoing clinical trials that are evaluating various stent prototypes. Developmental stents that use radiopaque and bioabsorbable materials are presented. The potential role for intravascular stents as vehicles for localized drug delivery and gene therapy is discussed.

AB - Intravascular stents have been developed to address acute arterial closure and restenosis, the major limitations of percutaneous transluminal coronary angioplasty (PTCA). Metallic stents in human clinical trials have shown efficacy in treating acute closure and, in selected patients, lowering the restenosis rate. This review delineates the characteristics of the ideal stent and examines ongoing clinical trials that are evaluating various stent prototypes. Developmental stents that use radiopaque and bioabsorbable materials are presented. The potential role for intravascular stents as vehicles for localized drug delivery and gene therapy is discussed.

UR - http://www.scopus.com/inward/record.url?scp=0025740769&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025740769&partnerID=8YFLogxK

U2 - 10.1016/1050-1738(91)90007-2

DO - 10.1016/1050-1738(91)90007-2

M3 - Article

C2 - 21239328

AN - SCOPUS:0025740769

VL - 1

SP - 127

EP - 131

JO - Trends in Cardiovascular Medicine

JF - Trends in Cardiovascular Medicine

SN - 1050-1738

IS - 3

ER -